²é¿´: 1404  |  »Ø¸´: 8
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

angelhunte

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²ËÄñ

[ÇóÖú] »ÔÈðÐÂÉÏÊеÄÐÂÒ©crizotinibµÄALKøÒÖÖÆÂÊÊǶàÉÙ£¬Èç¹ûÓÐÎÄÏ×»á×·¼Ó100½ð±Ò

»ÔÈðÐÂÉÏÊеÄÐÂÒ©crizotinibµÄALKøÒÖÖÆÂÊÊǶàÉÙ£¬Èç¹ûÓÐÎÄÏ×»á×·¼Ó100½ð±Ò
»Ø¸´´ËÂ¥
Çó¹¤×÷
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

angelhunte

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²ËÄñ

ÒýÓûØÌû:
2Â¥: Originally posted by songxiangen at 2012-09-18 11:35:33
Crizotinib (PF-02341066) µÄÉúÎï»îÐÔ
Inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK(nucleophosmin-anaplastic lymphoma kinase) fusion protein. A t(2;5) chromosomal translocation r ...

ϸ°û»îÐÔ£¬ÎÒÒªµÄÊÇø»îÐÔ£¬Óб¨µÀ˵СÓÚ1nM,µ«²»ÖªµÀ¾ßÌåÊý¾Ý
Çó¹¤×÷
3Â¥2012-09-18 15:02:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 9 ¸ö»Ø´ð

songxiangen

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:32:53
Crizotinib (PF-02341066) µÄÉúÎï»îÐÔ
Inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK(nucleophosmin-anaplastic lymphoma kinase) fusion protein.[1] A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as NPM-ALK has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL). [2]
After incubation with Crizotinib (PF-02341066), cells were washed once with HBSS supplemented with 1 mmol/L Na3VO4 and protein lysates were generated. Subsequently, phosphorylation of ALK was assessed by a sandwich ELISA method using an immobilized anti¨Ctotal-ALK antibody and an anti¨Cphospho-ALK antibody (pY1604) as a detec ion antibody.
Crizotinib (PF-02341066) inhibited NPM-ALKphosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value=24 nM).
Crizotinib (PF-02341066) potently inhibited cell proliferation, which was associated with G1-S¨Cphase cell cycle arrest and induction of apoptosis in ALK-positive ALCL cells (IC50 values=30 nM) but not ALK-negative lymphoma cells. The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase¨Cmediated nick-end labeling and Annexin V staining (IC50 values=25¨C50 nM). [3]

Crizotinib (PF-02341066) ²Î¿¼ÎÄÏ×
[1] Blood 2005;105: 2640-2653
[2] Oncogene 2001;20:5623-5637
[3] Mol Cancer Ther 2007;6:3314-3322

²»ÖªµÀ¶ÔÂ¥Ö÷ÓÐûÓÐÓÃ
2Â¥2012-09-18 11:35:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¶¬¹ÏÝæÝæ

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
angelhunte: ½ð±Ò+8, ¡ïÓаïÖú, ÖÁÉÙ˵Ã÷ÄúÈÏÕæ¿´¹ý 2012-09-18 22:37:21
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:32:59
»¹ÊÇÎÒÀ´Ó¦´ð°É£¡
crizotinibµÄALKøÒÖÖÆÂÊ99%£¨1΢Ħ¶ûŨ¶ÈÏ£©£¬ALKøÒÖÖÆIC50СÓÚ1nm¡£
²Î¿¼ÎÄÏ×£ºJournal of Medicinal chemistry 2011£¬ 54£¬ 6342-6363£¨Table¡£5.£©
4Â¥2012-09-18 16:41:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¶¬¹ÏÝæÝæ

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, ÈÈÐĽ±Àø 2012-09-20 08:33:12
¼û¸½¼þͼƬÊý¾Ý

crizotinib.JPG

5Â¥2012-09-18 16:49:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 303Çóµ÷¼Á +3 î£08 2026-03-17 5/250 2026-03-17 22:01 by î£08
[¿¼ÑÐ] 085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ +4 share_joy 2026-03-16 4/200 2026-03-17 21:32 by hmn_wj
[¿¼ÑÐ] ¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985 +4 ÕÅvvvv 2026-03-15 6/300 2026-03-17 17:15 by ruiyingmiao
[¿¼ÑÐ] ²ÄÁÏר˶326Çóµ÷¼Á +6 Ä«ìÏæ¦Ý· 2026-03-15 7/350 2026-03-17 17:10 by ruiyingmiao
[¿¼ÑÐ] ¡¾0856¡¿»¯Ñ§¹¤³Ì£¨085602£©313 ·Ö£¬±¾¿ÆÑ§¿ÆÆÀ¹ÀAÀàԺУ»¯Ñ§¹¤³ÌÓ빤ÒÕ£¬³ÏÇóµ÷¼Á +7 СÁõ¿ì¿ìÉϰ¶ 2026-03-11 8/400 2026-03-17 16:57 by ruiyingmiao
[¿¼ÑÐ] 08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á +4 À滨çóÍí·ç 2026-03-17 4/200 2026-03-17 13:38 by houyaoxu
[˶²©¼ÒÔ°] ÉîÛÚ´óѧ˶ʿÕÐÉú£¨2026Ç´«¸ÐÆ÷·½Ïò£¬½ö¼ȡµÚÒ»Ö¾Ô¸£© +4 xujiaoszu 2026-03-11 9/450 2026-03-17 10:29 by xujiaoszu
[¿¼ÑÐ] ²ÄÁÏר˶274Ò»Ö¾Ô¸ÉÂÎ÷ʦ·¶´óѧÇóµ÷¼Á +5 Ñ¦ÔÆÅô 2026-03-13 5/250 2026-03-17 10:15 by Sammy2
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á +7 Çñgl 2026-03-11 8/400 2026-03-17 09:36 by ŬÁ¦Ñ§Ï°×¬²ÊÀñ
[¿¼ÑÐ] 267Ò»Ö¾Ô¸ÄϾ©¹¤Òµ´óѧ0817»¯¹¤Çóµ÷¼Á +6 SUICHILD 2026-03-12 6/300 2026-03-17 09:24 by ÎíÉ¢ºóÏàÓölc
[¿¼ÑÐ] 278Çóµ÷¼Á +3 Yy7400 2026-03-13 3/150 2026-03-17 08:24 by laoshidan
[¿¼ÑÐ] »úеר˶325£¬Ñ°ÕÒµ÷¼ÁԺУ +3 y9999 2026-03-15 5/250 2026-03-16 19:58 by y9999
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] 070305Çóµ÷¼Á +3 mlpqaz03 2026-03-14 4/200 2026-03-15 11:04 by peike
[¿¼ÑÐ] ²ÄÁÏ080500µ÷¼ÁÇóÊÕÁô +3 Ò»¿Åmeteor 2026-03-13 3/150 2026-03-14 10:54 by peike
[¿¼ÑÐ] 330Çóµ÷¼Á +3 ?½´¸øµ÷¼Á¹òÁË 2026-03-13 3/150 2026-03-14 10:13 by JourneyLucky
[¿¼ÑÐ] ÕÐÊÕ0805£¨²ÄÁÏ£©µ÷¼Á +3 18595523086 2026-03-13 3/150 2026-03-14 00:33 by 123%¡¢
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»´ó£¬²ÄÁÏר˶317Çóµ÷¼Á +5 lx8568 2026-03-11 5/250 2026-03-13 21:43 by peike
[¿¼ÑÐ] 304Çóµ÷¼Á +7 7712b 2026-03-13 7/350 2026-03-13 21:42 by peike
[¿¼ÑÐ] »¯¹¤Ñ§Ë¶306Çóµ÷¼Á +9 42838695 2026-03-12 9/450 2026-03-13 10:16 by houyaoxu
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û